OBSTRUCTIVE APNEA COMORBID SYNDROME WITH CHRONIC BRAIN IHEMIA AND ARTERIAL HYPERTENSION
Obstructive sleep apnea syndrome (OSA) is currently regarded as one of the significant risk factors for the development of neurovascular and cardiovascular diseases and their complications. Hypoxia and hypersimpicotonia, underlying their development, increase the risk of neurovascular and cardiovascular pathology several times. Mortality from cardiovascular and neurovascular diseases with sleep disorders over the last decade has increased 7 times. Currently, dissatisfaction with the quality of their sleep is found in 30-45% of the population, and the prevalence of OSA in the population is 10-12%. When identifying patients with OSA, you should clearly focus on 7 symptoms: respiratory arrest in a dream (according to relatives) and suffocation during sleep, frequent waking up; loud intermittent snoring and morning headaches, night sweats and dry mouth after waking up; increased daytime sleepiness, not bringing recuperation and a constant feeling of tiredness during the daytime with a violation of concentration and attention; frequent night urination and decreased potency; violation of night sleep for more than six months; overweight and / or obesity; arterial hypertension (AH) - especially night or morning rise in blood pressure (BP), and in children - paradoxical movements of the chest in a dream. At the same time, cognitive impairment is also possible: irritability and memory loss.